312-422-1111 ibioadmin@ibio.org
Global Plasma Leaders Collaborate to Accelerate Development of Potential COVID-19 Hyperimmune Therapy

CSL Media Statement on Coronavirus

Coronavirus is quite different to influenza virus so it is not a core area of focus for CSL or Seqirus. However, we have investigated possible adjacencies in expertise, technologies and facilities that might be able to contribute to the global effort and are pleased...
X